|
Cellular type/Perfusion | Treatment | Dose | Insulin release | Glucose output | Reference |
|
Islets from normal rats | AG + glucose versus glucose | 10-12 M AG + 2.8 mM glucose | Not change | |
[54] |
AG + glucose versus glucose | 10-12 M AG + 8.3 mM glucose | Enhanced | |
|
Islets from normal rats | AG + glucose versus glucose | 10-8 M AG + 2.8 mM glucose | Not change | |
[58] |
AG + glucose versus glucose | 10-8 M AG + 8.3 mM glucose | Diminished | |
|
Islets from normal rats | AG + glucose versus glucose | 10 nM AG + 20 mM glucose | Diminished | |
[92] |
UAG + glucose versus glucose | 1 M + 20 mM glucose | Not change | |
AG + glucose + YIL-781 versus glucose | 10 nM AG + 20 mM glucose + 1 M YIL-781 | Not change | |
Glucose + YIL-781 versus glucose | 20 mM glucose + 1 M YIL-781 | Not change | |
|
Islets from normal rats | GHRP-6 versus placebo | 1 M GHRP-6 | Enhanced | |
[58] |
SPA versus placebo | 1 M SPA | Enhanced | |
|
Ghrelin KO mouse islets | Glucose ghrelin KO versus glucose wildtype | 8.3 mM and 16.7 mM glucose | Enhanced | | [91] |
|
Min 6 cells | AG + glucose versus glucose | 1–10 nM AG + 22.2 mM glucose | Diminished | | [93] |
|
Hepatocytes from pigs | AG versus placebo | 100 nM AG | | Enhanced |
[96] |
UAG versus placebo | 100 nM UAG | | Diminished |
UAG + AG versus AG | 100 nM AG + 100 nM UAG | | Diminished |
|
Pancreas of rat perfused in situ | Ghrelin + glucose versus glucose | 10 nM ghrelin + 5.5 mM glucose | Not change | |
[90] |
Ghrelin + glucose versus glucose | 10 nM ghrelin + 9 mM glucose | Diminished | |
|
Pancreas of rat perfused in vitro | Ghrelin + glucose versus glucose | 10 nM ghrelin + 8,3 mM glucose | Diminished | |
[91] |
GHRP-6 + glucose versus glucose | 1 M GHRP-6 + 8.3 mM glucose | Enhanced | |
UAG + glucose versus glucose | 10 nmol/l UAG + 8.3 mM glucose | Not change | |
|